Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124051762 | 12405176 | 2 | F | 2011 | 20160810 | 20160525 | 20160818 | EXP | US-DSJP-DSU-2016-117157 | DAIICHI | 0.00 | Y | 0.00000 | 20160817 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124051762 | 12405176 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | Y | Y | 21286 | 40 | MG | TABLET | QD | ||||
| 124051762 | 12405176 | 2 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | Y | Y | 21286 | 40 | MG | TABLET | QD | ||||
| 124051762 | 12405176 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG,HALF TAB QD | 0 | 25 | MG | TABLET | QD | ||||||
| 124051762 | 12405176 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
| 124051762 | 12405176 | 5 | C | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | UNK, QD | 0 | QD | |||||||||
| 124051762 | 12405176 | 6 | C | LASIX | FUROSEMIDE | 1 | 20 MG, QOD | 0 | 20 | MG | TABLET | ||||||||
| 124051762 | 12405176 | 7 | C | LASIX | FUROSEMIDE | 1 | 40 MG, QD | 0 | 40 | MG | TABLET | QD | |||||||
| 124051762 | 12405176 | 8 | C | POTASSIUM | POTASSIUM | 1 | Oral | 10 MEQ, QD | 0 | 10 | MEQ | TABLET | QD | ||||||
| 124051762 | 12405176 | 9 | C | NIFEDICAL XL | NIFEDIPINE | 1 | Oral | 30 MG, QD | 0 | 30 | MG | QD | |||||||
| 124051762 | 12405176 | 10 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 | ||||||||||||
| 124051762 | 12405176 | 11 | C | DICLOFENAC | DICLOFENAC | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124051762 | 12405176 | 1 | Hypertension |
| 124051762 | 12405176 | 3 | Hypertension |
| 124051762 | 12405176 | 5 | Type 1 diabetes mellitus |
| 124051762 | 12405176 | 6 | Product used for unknown indication |
| 124051762 | 12405176 | 8 | Product used for unknown indication |
| 124051762 | 12405176 | 9 | Product used for unknown indication |
| 124051762 | 12405176 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124051762 | 12405176 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124051762 | 12405176 | Acute kidney injury | |
| 124051762 | 12405176 | Coeliac disease | |
| 124051762 | 12405176 | Cognitive disorder | |
| 124051762 | 12405176 | Decubitus ulcer | |
| 124051762 | 12405176 | Gastroenteritis | |
| 124051762 | 12405176 | Hiatus hernia | |
| 124051762 | 12405176 | Hypotension | |
| 124051762 | 12405176 | Malabsorption | |
| 124051762 | 12405176 | Pancreatic cyst | |
| 124051762 | 12405176 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124051762 | 12405176 | 1 | 201004 | 201306 | 0 | |
| 124051762 | 12405176 | 2 | 20130704 | 0 |